Skip to main content
. Author manuscript; available in PMC: 2023 Jul 17.
Published in final edited form as: Vaccine. 2022 Feb 10;40(12):1810–1820. doi: 10.1016/j.vaccine.2022.02.006

Table 2.

Diphtheria and tetanus antibody levels among children born in 2006–2015 by survey site — Ukraine, 2017

Antibody levels, IU/mL Diphtheria Tetanus
No. Adjusted % (95% CI) Median, IU/mL No. Adjusted % (95% CI) Median, IU/mL
Zakarpattya (N = 1,306) 0.09 0.26
 <0.01 256 18.7 (13.0–26.1) 292 21.5 (14.6–30.6)
 0.01–0.09 416 31.3 (27.7–35.2) 23 16.9 (13.7–20.6)
 0.1–0.9 427 33.8 (28.4–39.6) 347 27.1 (22.9–31.7)
 ≥1.0 207 16.2 (12.7–20.5) 435 34.5 (28.0–41.7)
Sumy (N = 1,403) 0.42 1.56
 <0.01 59 4.4 (3.2–6.2) 59 4.4 (3.3–5.8)
 0.01–0.09 261 19.3 (16.3–22.7) 90 6.5 (4.6–9.0)
 0.1–0.9 635 44.5 (41.1–47.8) 373 26.6 (23.4–30.1)
 >1.0 448 31.8 (28.6–35.2) 881 62.5 (57.4–67.4)
Odessa (N = 1,298) 0.29 0.94
 <0.01 96 7.9 (5.8–10.8) 93 7.9 (5.5–11.1)
 0.01–0.09 294 22.8 (19.8–26.1) 145 11.5 (9.2–14.2)
 0.1–0.9 579 44.2 (40.7–47.9) 435 32.9 (29.1–36.9)
 ≥1.0 329 25.1 (21.9–28.4) 625 47.8 (43.1–52.5)
Kyiv City (N = 722) 0.42 1.23
 <0.01 25 3.5 (2.3–5.2) 30 4.3 (3.0–6.2)
 0.01–0.09 128 17.3 (15.3–19.5) 53 6.8 (4.8–9.5)
 0.1–0.9 357 49.2 (43.7–54.7) 239 32.4 (27.3–38.0)
 ≥1.0 212 30.0 (27.1–33.1) 400 56.4 (51.1–61.6)

Antibody levels <0.01 IU/mL correspond to no protection, 0.01–0.09 IU/mL – to minimal protection, and ≥0.1 IU/mL to full protection, including 0.1–0.9 IU/mL, linked to shorter-term protection, and ≥1.0 IU/mL, associated with long-term protection